Reuters logo
3 个月前
BRIEF-Adaptimmune reports initiation of study to evaluate spear t-cell therapy
2017年5月16日 / 中午12点14分 / 3 个月前

BRIEF-Adaptimmune reports initiation of study to evaluate spear t-cell therapy

May 16 (Reuters) - Adaptimmune Therapeutics Plc:

* Adaptimmune announces initiation of study to evaluate spear t-cell therapy targeting mage-a4 in multiple solid tumors

* Adaptimmune Therapeutics Plc - phase i, open label, dose escalation study to evaluate mage-a4 will enroll up to 32 patients Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below